Musk Allegedly Used Drugs While Serving as Advisor, Claims The New York Times

International Desk

Elon Musk, the billionaire entrepreneur and one of the most prominent figures in global technology, has been accused of regularly using drugs while actively participating in U.S. politics.

An investigative report by The New York Times alleges that Musk consumed drugs like ketamine, ecstasy, and psychedelic mushrooms during his tenure as a close advisor to President Donald Trump. The publication of this report has sparked significant controversy.

The report claims that Musk consumed ketamine almost daily and carried a box containing about 20 types of drugs. Musk himself reportedly admitted in an interview to taking small amounts of ketamine every two weeks. However, by late 2023, his drug use allegedly escalated to levels that became physically harmful, reportedly causing bladder problems.

The Times also reported that Musk’s drug use intensified during his involvement in Trump’s reelection campaign, to which he donated \$275 million, and while he headed the U.S. Department of Government Efficiency (DOGE).

During this period, Musk participated in critical meetings and played an active role in budgetary and policy-making decisions. However, there has been no comment from the White House regarding whether his drug use influenced these responsibilities.

According to the U.S. Drug Enforcement Administration (DEA), ecstasy is classified as a Schedule 1 drug with no recognized medical use and is strictly prohibited for federal employees. However, the report suggests that Musk’s classification as a special category government employee may have allowed for relaxed enforcement of some regulations in his case.

Musk has not yet responded to the allegations made in The New York Times report.